Ofev is indicated in adults for the treatment of idiopathic pulmonary fibrosis (IPF).
Ofev is also indicated in adults for the treatment of other chronic fibrosing interstitial lung diseases (ILDs) with a progressive phenotype (see Pharmacology: Pharmacodynamics under Actions).
Ofev is indicated in adults for the treatment of systemic sclerosis associated interstitial lung disease (SSc-ILD).